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Abstract
Acute and chronic tendon injuries are very common among athletes and in sedentary population.
Most physicians prescribe anti-inflammatory managements to relieve the worst symptoms of
swelling and pain, including non-steroidal anti-inflammatory drugs, corticosteroids and physical
therapies. However, experimental research shows that pro-inflammatory mediators such as
prostaglandins may play important regulatory roles in tendon healing. Noticeably nearly all cases of
chronic tendon injuries we treat as specialists have received non-steroidal anti-inflammatory drugs
by their physician, suggesting that there might be a potential interaction in some of these cases
turning a mild inflammatory tendon injury into chronic tendinopathy in predisposed individuals. We
are aware of the fact that non-steroidal anti-inflammatory drugs and corticosteroids may well have
a positive effect on the pain control in the clinical situation whilst negatively affect the structural
healing. It follows that a comprehensive evaluation of anti-inflammatory management for tendon
injuries is needed and any such data would have profound clinical and health economic importance.
Sporting injuries, including both acute trauma and
chronic overuse, are usually presented with clinical signs
of swelling and pain. Most sport medicine physicians pre-
scribe anti-inflammatory managements to control the
pain. However, there are increasing evidences about the
unfavorable side effects on the use of various anti-inflam-
matory agents for tendon injuries.
Do we need to re-visit the rationale of this 
practice?
In cases of chronic tendinopathy, a lack of inflammatory
infiltration in the biopsies has challenged the status of
"tendinitis". However, it did not rule out the possibility of
an inflammatory response in the early development of
tendinopathy. Overuse or repetitive stretching on tendons
triggered the release of pro-inflammatory mediators,
which can induce expression of metalloproteinases and
leads to collagen degradation. These findings suggest that
inflammatory responses play a key role in the develop-
ment of degenerative overuse tendon injuries. Together
with the fact that all chronic tendinopathy cases received
anti-inflammatory management, it is logical to assume
that suppression of inflammatory responses may interact
with the failed healing of degenerative tendon injuries.
We coined the term failed healing to describe the his-
topathological characteristics of tendinopathy samples,
which exhibited traits of both active repair and degenera-
tive injuries. The development of overuse animal model
clearly demonstrated the casual relationship of overuse
and degenerative tendon injuries through activation of
inflammatory mediators [1], but whether the injured ten-
dons failed to heal in these models were not adequately
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described. On the other hand, animal models of colla-
genase-induced degenerative injuries revealed failed heal-
ing [2] and longstanding pain [3]. We believe that chronic
tendinopathy is a result of failed healing of degenerative
injuries (Figure 1). The reasons why the degenerative inju-
ries fail to heal might be the core of the mystery. Since pro-
inflammatory mediators affect various cellular activities
related to tendon healing, it is possible that anti-inflam-
matory agents might negatively affect tendon healing and
contribute to the development of tendinopathy.
Non-steroidal anti-inflammatory drugs 
(NSAIDs)
It is still a common practice to prescribe non-steroidal
anti-inflammatory drugs (NSAIDs) which primarily work
by inhibiting the production of pro-inflammatory pros-
taglandins. Interestingly, both beneficial and deleterious
effects of NSAIDs on tendon healing were reported. It
appears that NSAIDs exerted beneficial effects, if any, by
influencing the remodeling of collagen matrix, resulting
in reduction of cross-sectional area of the healing tendons
but tensile strength may or may not be affected. NSAID
may also negatively affect early tendon healing, as pros-
taglandin E2 (PGE2) is essential for early tendon healing
such as control of vascular flow. We doubt that the
unchecked use of NSAIDs may exert negative effects when
prescribed to tendinopathy patients. As increased expres-
sion of cyclooxygenase 2 (COX-2) and increased produc-
tion of PGE2 were found in chronic tendinopathy samples
[4], the involvement of PGE2 for the development of
chronic tendinopathy was implied. As PGE2 may mediate
the development of overuse tendon injury by induction of
metalloproteinases, it is possible that suppression of PGE2
may have reduced the extent of degenerative injuries but
the normal matrix remodeling would also be affected,
which may contribute to the failed tendon healing. Fur-
ther investigation is urgently needed to disseminate the
double-edged properties of prostaglandins in tendon
healing before we could advocate the use of NSAIDs for
chronic or acute tendon injuries.
Corticosteroids
Corticosteroids are strong anti-inflammatory agents and
peri-tendinous injection of corticosteroid is commonly
used to treat the chronic pain in tendinopathy. However,
the use of corticosteroid may increase risk of spontaneous
ruptures and the deleterious effects of corticosteroid were
demonstrated on culture human tendon fibroblasts,
including cell viability, proliferation and matrix synthesis
[5]. In spite of its potential hazards, corticosteroid injec-
tions are still given indiscriminately in many sport clin-
ics!! There is no doubt that the adverse effect of
corticosteroids on tendon cells would affect the healing
responses to degenerative injuries, corticosteroid injection
should be considered as a last resort with careful control
on the dosages.
Other anti-inflammatory modalities
Apart from NSAIDs and corticosteroids, the use of physi-
cal therapies to reduce inflammatory signs in tendon inju-
ries is common, but rigorous scientific studies on the
efficacy and the underlying mechanisms are not available.
Pulsed electromagnetic fields and low level laser treat-
ments may reduce inflammation, probably by suppress-
ing PGE2  production. The therapeutic effect of
extracorporeal shockwave therapy may be attributed to its
anti-inflammatory actions through modulation of nitric
oxide production. It appears that these biophysical inter-
ventions also exerted anti-inflammatory actions through
modulation of pro-inflammatory mediators. As they are
relatively safe, further exploration to consolidate their effi-
cacies may yield a better clinical practice for anti-inflam-
matory management for tendon injuries.
It would be a breakthrough if we could identify disturbed
prostaglandin levels as one of the causes of failed healing
in tendinopathy, which will certainly guide the develop-
ment of effective treatment strategies for overuse tendon
injuries. In most clinical practice, it is very difficult to
monitor the use of anti-inflammatory management for
chronic tendinopathy, let alone restricting it in a rigid pro-
tocol.
Overuse or excessive mechanical stimulation to tendons can  lead to elevation of metalloproteinases (MMPs) which medi- ate collagen degradation and hence degenerative tendon inju- ries Figure 1
Overuse or excessive mechanical stimulation to ten-
dons can lead to elevation of metalloproteinases 
(MMPs) which mediate collagen degradation and 
hence degenerative tendon injuries. Healing responses 
are activated but failed to repair the degenerative injuries, 
resulting in tendinopathy. It is possible that anti-inflammatory 
management may affect the development of degenerative 
injuries as well as the pathological processes of failed healing 
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